NCT07143019

The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-03-16Est. Completion: 2027-07

Enrollment target: 214 participants

Locations

Barrow Neurological Institute, Phoenix, Arizona, United States
UCSF Medical Center, San Francisco, California, United States
University of Colorado Anschutz, Aurora, Colorado, United States
Swedish Medical Research Center, Englewood, Colorado, United States
Baptist Health Research Institute, Jacksonville, Florida, United States
Piedmont Atlanta Hospital, Atlanta, Georgia, United States
Advocate Lutheran General Hospital, Park Ridge, Illinois, United States
University of Iowa, Iowa City, Iowa, United States
Tufts Medical Center, Boston, Massachusetts, United States
WashU Medicine, St Louis, Missouri, United States
UBNS, Buffalo, New York, United States
North Shore University Hospital - Northwell Health, Manhasset, New York, United States
NYU Langone Health, New York, New York, United States
NewYork-Presbyterian / Weill Cornell Medical Center, New York, New York, United States
Stony Brook University Hospital, Stony Brook, New York, United States
East Carolina University Health Medical Center, Greenville, North Carolina, United States

Diffuse Large B-cell Lymphoma (DLBCL)CardiotoxicityLymphoma

This trial is to evaluate if dexrazoxane is safer and more effective than liposomal doxorubicin in preventing heart fail…

Boston, United StatesEst. completion Dec 31, 2030

Cavernous Angioma, FamilialCerebral Cavernous MalformationsCerebral Cavernous Hemangioma

Cerebral cavernous malformations (CCMs) are clusters of abnormal blood vessels in the brain and spine. CCMs can bleed an…

Phoenix, United StatesCompleted Mar 31, 2025

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.